XNAS: GLSI
Greenwich LifeSciences Inc Live Stock Price Today, Share Analysis and Chart
about
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane pepti...
Read More
23.70
0.08
(0.34%)
115.3K
XNAS Volume
XNAS 01 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Greenwich LifeSciences Inc is on 06 May 2026 for the purpose of Greenwich LifeSciences Inc Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Greenwich LifeSciences Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..